TNFRSF10B and plasma cell myeloma: We have observed the decreased expression of TP53[21] which directly affects TRAIL-R2 levels in myeloma cell lines[22] but decreased TP53 expression in MM cells carrying del(8)(p21) did not lead to downregulation of TRAIL-R2 expression neither at the mRNA level nor at the cell surface.